Solid dispersion is an attractive tool of pharmaceutical technology used to improve the physical properties of drugs, among these properties is the solubility of the drugs.
Mechanisms for its therapeutic effect in PUD involves stimulating the generation of prostaglandins, enhanced mucosal protection, removal of oxygen free radicals and inhibiting the production of inflammatory cytokines (2) . Clinical investigations have shown that it has marked effects on ulcer healing and helicobacter pylori (HP) adhesion. Research has shown that the REM levels presented in the gastric mucosa and gastric mucus were a result of local penetration, and the local concentration allows it to exhibit a variety of antiulcer effects after oral administration (3) . REM is classified as a class IV based on the biopharmaceutical classification system, due to its low water solubility and permeability, the bioavailability of rebamipide is under 10% in humans. To increase the low solubility of poor water soluble drug and improve its bioavailability, several strategies can be employed, such as size reduction, use of surfactants, pH adjustment, and complexation with cyclodextrines, emulsions and solid dispersion (4) . Solid dispersion technologies are used for improving oral absorption and bioavailability of BSC class II and IV drugs, in solid dispersion drug disperse in the matrix generally a hydrophobic drug is dispersed in a hydrophilic matrix, which forms a solid dispersion. When the solid dispersion interacts with gastrointestinal fluid, the carrier or polymer which enhances solubility of drug it first dissolves and the drug release as fine colloidal particles. This result in enhanced surface area produces higher dissolution rate and bioavailability of poor water soluble drug (5) . Many polymers have been used for SD , like pluronic F-127 , polyethelen glycol (PEG), polyvinylpyrrolidon (PVP).
To enhance the solubility and then the dissolution of the drugs (6) .
Materials and Methods

Materials
Rebamipide was obtained from apopharm, China, Pluronic F-127 from sigma, USA, PEG 6000 from Chemifine chemicals. Mumbai, India , PVP K30 from Hyper Chem, China and (TPGS) from Hyper Chem, China , while methanol from Sigma-Aldrich Co., Germany. All other reagents were of analytical grade.
Preparation of REM-solid dispersionsolvent evaporation method
Rebamipide solid dispersion were prepeared by solvent evaporation method. Using different carriers (Pluronic F-127, PEG 6000, PVP K30 and TPGS) in different ratios as shown in Table ( 1), the drug and carriers; were taken separately in different ratios(1:9,1:12and1:15) wt:wt and transferred in a beaker containing appropriate amounts of methanol (solvent).By using magnetic stirrer,then the two solutions was mixed together on magnetic stirrer. The solvent was removed by leaving it for 24 hr. at room temperature (25-30 °C).The dried solidifing mass were scraped, crushed and grinded in mortar and pastle to pass through the sieve no 20 and strored in aglass umber container in a deiccator for subsequent study (7) .
Fusion method
In fusion method, accurate amount of carriers and drug in the different ratio (1:9, 1:12, 1:15). The carrier was first melted in Petri-dish at the melting point of each polymer and the drug was dispersed in the molten mixture with constant stirring then cooled it. The dried mass was crushed and grinded in mortar and pastle to pass through sieve no.20 and store in desiccator (8) . A modification of the above method when used PVP K30, have been prepared by closed melting point method. This method includes the addition of water to the carrier and heated, the drug dispersed in the heated mixture with constant stirring then cooled it. The dried mass was crushed and grinded in mortar and pastle to pass through sieve no.20 and store in desiccator (9) .
Kneading method
An accurate weighted quantity of drug and corresponding water soluble carrier (Table  1) , are mixed together in glass mortar, and triturate for 30 minutes, with drop by drop distilled until get the structure paste, the paste was spread over suitable Petri-dish and dried in oven at 40°C for 24 hours. (Except in TPGS polymer, the temp. was 25°C. The dried mass was crushed and grinded in mortar and pastle to pass through sieve no.20 and store in desiccator 
Characterization of REM-solid dispersion Determination of percent production yield of prepared REM-solid dispersion
The percent of production yield (PY %) of prepared REM -solid dispersion was determined by calculating the ratio of actual weight of the obtained solid dispersion on the theoretical weight of solid dispersion using the following equation (11) :
Solubility studies of rebamipide solid dispersion An excess amount of pure REM and prepared REM-solid dispersion were placed in contact with ten milliliters of water in closed tight container that shakes continually for 72 hr. in thermo-control water bath at 25°C. After the removal from the shaker water bath, the tubes put in centrifuge for 10 min at 4000 rpm. The solutions were filtered through a 0.45 µm filter membrane, and the concentration of REM was determined by UV -spectrophotometer at λmax.227 nm wavelength the study was done in triplicate (12) .
Drug content analysis
The REM solid dispersion equivalents to 100mg of rebamipid were taken and dissolved in 100 mls. of methanol, then filtered by using 0.45µm filter membrane. The filtrate was suitably diluted with methanol; the drug solution was analyzed by using UVspectrophotometer at λ max.
227 nm wavelengths. The percentage of drug content in solid dispersion was calculated by using the following equation:
In-vitro dissolution studies The in-vitro release of REM in the solid dispersion was determined and compared with pure rebamipide drug by using USP XXII rotating paddle apparatus (II). REM-solid dispersion equivalents to 100 mg of pure drug were dispersed in dissolution medium surface. The dissolution medium employed for drug release study was 900 milliliters. of 0.1N HCl, maintained at 37.5 ±0.5°C by means of thermostatic water bath and under shaking provide by the paddle at 100 rpm (14) . Five milliliters were withdrawn at (1,3,5,10,15,30,45,60,90,120) minutes time interval for two hours, and each withdrawn sample was replaced with an equal volume of fresh 0.1 N HCl dissolution medium as soon as to maintain sink condition. The samples were filtered through 0.45µm filter membrane and analyzed by UV-spectrophotometer at λmax 227 nm wavelengths (15) .
Factors affecting dissolution behavior of REM from solid dispersion
The effect of different polymer types (Pluronic F-127, PEG 6000, PVP K30 and TPGS) on dissolution behavior of REM from solid dispersion was studies on the formulas SD1, SD10, SD19 and SD28.
The effect of different drug: polymer ratio on dissolution behavior of REM from solid dispersion was studies on the formulas (SD1-SD3), (SD10-SD13), (SD19-21), (SD28-SD30), which they are belong to the solvent evaporation method.
The effect of preparation method on dissolution behavior of REM from solid dispersion was studies on the formulas (SD1, SD4, SD7), (SD10, SD13, SD16), (SD19, SD22, SD25) and (SD28, SD31, SD34).
The solubility and in-vitro dissolution profile were used for selecting the best formula which will be subjected to further analysis.
Evaluations of selected solid dispersion formula Fouier transforms infrared spectroscopy (FTIR)
The FTIR of pure REM and selected formula were performed to investigate drugpolymer the interaction. The samples were compressed with potassium bromide as a disc, and carried out by FTIR Shimadzu 8000 Japan; the scanning range the spectrum obtained was in between the wave number of 4000-400 cmˉ¹ (16) .
Differential scanning calorimeter (DSC)
Thermal characteristic of the selected formula and TPGS characterized by an automatic thermal analyzer system (Shimadzu, DSC-60, Japan). Approximately 5 mg of samples were placed in none hermetically aluminum pan and heated at rate 10°C/ min over temperature 25°C to 400°C (17) .
Powder x-ray diffraction (PXRD)
Powder x-ray diffraction is instrument used to study the molecular structure of crystalline substance such as drug and optimum formula. The degree of crysallinity was determined by (XRD-6000, Shimadzu, Japan 220V/50Hz).
X-Ray diffractometer with Cu-Ka radiation at 40 Kv and 30 mA. Samples were scanned over a 2θ range of 30-80 ° at step size of 0.02° (18) .
Scanning electron microscopy (SEM)
Scanning electron microscope of the selected formula and pure drug (REM) were analyzed using (Shimadzu, Japan); in order to examination the external morphology and shape of the particle. The samples coated with layer of gold at room temperature under Argon gas. The SEM was operated at a high vacuum with accelerating voltage of 5-15 KV. Secondary electron images were recorded digitally at higher magnification (19) .
Statistical Analysis
The results of the experiments were given as a mean for triplicates samples ± stander deviation and were analyzed according to oneway analysis of variance (ANOVA) test level of (P<0.05) was considered to be statistically significant, and non-significant value with (P>0.05).
Results and Disscution
Determination of rebamipide saturated solubility
The solubility of REM in different media (water, 0.1 N HCl, phosphate buffer pH 6.8) at 25 °C was determined. The results revealed that the solubility of REM is very poor in 0.1 N HCl pH (1.2), which may be attributed to it is acidic nature of the drug, so increasing the pH of the solvent using phosphate buffer lead to increase the solubility from 1.8µg/ml (pH 1.2) to 1320 µg/ml at pH6.8 (730 x fold). And the solubility of REM in water was 23.9µg/ml as shown in Table ( 2). On the other hand, the solubility of REM at phosphate buffer pH6.8 (1320µg/ml) is still with a range of slightly soluble drug category. That it's why the mission of the study; to enhance the solubility of REM .
Characterization of REM -solid dispersion Determination of percent production yield of prepared REM-solid dispersion
The REM yield percentage was calculated to investigate best method of preparation of solid dispersion granules after drying, grinding and sieved through mesh size no. 20.
The solid dispersion granules were valid with percentage yield 76-99%, mainly for solvents and fusion methods.
This behavior may be attributed to the best entrapment or best solvation of REM particles by polymer used using melted carriers (fusion), or solvent vehicle (evaporation) methods.
Determination of REM content in prepared solid dispersion
Moreover the content of REM in solid dispersion was found in a range of 96.12% -100.2% in all prepared formulations, which is in the same range of U.S. Pharmacopoeia requirements (90-110%)
The above results indicated a uniform distribution of REM particles within polymers used in all prepared formulas (20) .
Determination of saturated solubility of REM in solid dispersion
The solubility study of rebamipide as a pure powder and as a drug loaded in solid dispersion formulas was carried out using distillated water maintained at 25°C temperature. Figure ( 2), (3) and (4) demonstrated that best result obtained, when TPGS used as a solid dispersion carriers compared with PVP K30, PEG 6000 and pluronic F-127 polymers the saturated solubility were 874.6 µg/ml, 180.1µg/ml, 59.6µg/ml, and 61.7 µg/ml., respectively using (1:15) drug polymer ratios, compared with 23.9 µg/ml for pure rebamipide powder
The last behavior of above polymers is significant (p<0.05), and increasing the solubility of REM may be referred to hydrophilic nature of all polymer used, besides hydrogen bonding formation between REM and carrier polymers to enhance the solubility (21) . On the other hand, TPGS was found as the best polymer carriers for REM with enhanced saturated solubility by 36.4 x fold compared with a pure REM. 
Factors affecting dissolution of rebamipide within solid dispersion particles Effect of polymer type
Figure (5) demonstrated that best results obtained for REM dissolution when TPGS polymer used among other hydrophilic polymers.
REM: polymer ratio (1:12) using solvent evaporation method demonstrated, that 70% of REM released in aqueous medium (p<0.05) was increased compared with 14%, 4%, and 2% for PVP k30, PEG6000 and pluronic F-127 polymers, respectively after 90 minutes.
This result was attributed to that TPGS has amphiphilic structure of lipophilic alkyl tail and hydrophilic polar head that lowering surface tension between REM and solvent, improvement of wetting characteristics and micellar solubilization of drugs (22) . In a focus of using surfactants like TPGS, the surface activity and self-emulsifing properties was gave the third generation type solid dispersion that's have highest degree of solubilization together with improving drug wet ability and spread ability by decreasing the interfacial tension between the drug particles and the aqueous medium, and also the amorphization of the crystalline drugs and avoiding recrystallization that can occur after contact with aqueous medium can further enhances the saturation solubility (23) . Meanwhile, the dissolution profile for REM-PVP K30 solid dispersion (SD19) had maximum percentage of 15.1% within 120 minutes, although PVP K30 inhibits crystal formation of drugs and resulting amorphous nature of drug in the solid dispersion and enhance the solubility of REM, but still lower than that of TPGS use (24) . 
Effect of carrier ratio
The effect of different drug: polymer ratio on the dissolution behavior of REM solid dispersion was studied, as shown in Figure (6) .
The figure represents the percent release profile of REM from solid dispersion of TPGS that prepared by solvent evaporation method. It was observed that as the ratio of TPGS increased in formulas (SD28-SD30), the drug release from solid dispersion was increased significantly (P<0.05). Formula SD30 appeared to have the highest the cumulative percent of REM release of 100% comparing to SD 29 of 47.8% and SD28 of 35.3% after 30 minutes.
The solid dispersions prepared with higher ratios of hydrophilic polymer could be offer more available space for surrounding of hydrophobic REM particle resulted in rapid hydration of drug molecules and consequently better wet ability and enhancement in the dissolution.
This may be attributed to TPGS melts and dissolves in the dissolution medium of 37°Cquickly and acts as an emulsifier of hydrophobic drugs (25) . Moreover, the transformation of crystalline nature of pure drug into the amorphous form as affirmed by DSC and PXRD result facilitates higher drug release rate over the pure drug (26) . 
Effect of preparation methods
The effect of preparation method on the dissolution behavior of REM from prepared drug-solid dispersion was studied.
Figure (7) shows the cumulative percent released of REM from the formulas contain TPGS in a ratio 1:15 that prepared by solvent evaporation, fusion and kneading methods, as in SD30, SD33, and SD36.
The results of dissolution of REM for individual samples (pure REM, solvent evaporation, fusion, and kneading methods) were noted, the cumulative percent of REM released after 15 minutes was 2.3%, 96.3 %, 75.3% and 53.2%, respectively. As shown in Figure (7) . The percent of REM release greatly improved with solvent evaporation method than fusion, kneading methods and pure rebamipide as a control , this can be attributed to the fact that solid dispersion prepared by solvent evaporation method result in more uniform and homogenous distribution of REM in hydrophilic TPGS polymer matrix as compared with other methods of preparation (27) . Moreover, when binary system comes in contact with an aqueous dissolution medium, the hydrophilic carrier dissolves and results in precipitation of embedded drug into fine particles, which increase the exposed surface area of the drug for the available dissolution surface (28) .
Selection of the best formula
The selection of the best formula was depended on the solubility study and the cumulative dissolution profile of REM from solid dispersion granules.
It could be concluded that the SD30 which contains REM-TPGS solid dispersion in a ratio 1:15 that prepared by solvent evaporation method was the best formula concerning higher solubility and better dissolution rate percent. Therefore, it was subjected into further in-vitro evaluations study.
Evaluation of selected formula Fourier transforms infrared spectroscopy (FTIR)
The FTIR spectrum for the pure REM, Figure (8) showed the characteristic peaks of the drug at 3276.47 cm¯¹ which are assigned to the N-H stretching vibration and 2938cm¯¹ due to C-H stretching of aromatic hydrocarbons, 1725.98 cm -1 due to C=O stretching of carboxylic acid and C=O of amide stretching at 1643.05 cm -1 and 1338.3 cm -1 due to C-N stretching, and 759.82 cm -1 due to C-H bending vibrations of aromatic ring (29) .
Figure 8. FTIR spectrum of rebamipide (REM)
The FTIR spectrum of selected formula (SD30) was shown in Figure ( and 1736.58 cm -1 for carbonyl groups in amide group and carboxyl functional group respectively, which demonstrated that there is no interaction between REM and TPGS when they incorporated as solid dispersion.
On the other hand, another bands were noticed at 2880.17 cm -1 and weak band at 3210 cmˉ¹ for both C-H stretching for aromatic ring and N-H (amine) stretching, respectively, that declare no interaction between REM and TPGS carrier in the SD30 formula (30) .
Figure 9. FTIR spectrum of selected formula of rem-tpgs (sd30)
Differential scanning calorimeter (DSC) DSC thermo grams of REM and TPGS are presented in Figures (10) and (11) which showed a sharp endothermic peak at 307.06°C and 40.68°C respectively, they revealed the crystal forms nature of drug and carrier.
Figure (12) represents the DSC thermo gram of REM-TPGS solid dispersion prepared by solvent evaporation method, the presence of single endothermic peak in thermo gram of SD30 at 39.69°C around the polymer melting point.
While the absence of endothermic peak of pure drug at 307.06°C in solid dispersion thermo gram could be due to the fact that the drug might transform from its crystalline form to amorphous form in the solid dispersion (SD30) formulation which can be further supported by PXRD (31) . 
Powder x-ray diffraction (PXRD)
The x-ray Diffraction analysis was carried out to confirm the change in the crystalline nature of the drug in solid dispersion and pure form. The x-ray Diffraction analysis of REM and solid dispersion are given in Figures (13) and (14) respectively. The drug characteristics peaks were observed at 21.7°, and 27.85° at 2θ value with intensity 821, and 736 respectively, the x-ray Diffraction pattern of REM-TPGS solid dispersion (1:15)peaks were observed at 21.7°at 122 and no characteristic peaks at 27.85°were obtain. The peak intensities were reduced, indicating the decreased in drug crystal structure, and converted to amorphous one, upon dispersion by solvent evaporation method (32) . The pure REM showed the crystalline appearance , while in SD30 showed irregular shaped glassy appearance in addition to size reduction and embedment. The smaller particle size as compared with pure drug size lead to great the wetted area, and hence the better the solubility (33) . 
